3 unknown, 2 completed, 1 terminated. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Drug Screening Assays, Antitumor: new trials by email Literature Review of Drug Screening Assays, Antitumor trials Research Report on Drug Screening Assays, Antitumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Computation Prediction of Drug Response Based on Omics Data virtual anti-cancer drug - Breast Cancer | Unknown | Peking University Cancer Hospital & Institute | 25 | 2023-02-15 | 2023-04-27 | |
| cl[Nical Study of Succide Among Patient With Psychoactive Substance Use Disorders drug screen - Substance Use Disorders | Unknown | Assiut University | 100 | 2021-12-01 | 2021-11-10 | |
| Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay antitumor drug screening assay, chemotherapy, biological therapy - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Not applicable | Completed | University of Washington | 16 | 2013-08-02 | 2018-07-11 |
| Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia Antitumor Drug Screening Assay, Dasatinib, Idelalisib - Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia | Phase 2 | Terminated | OHSU Knight Cancer Institute | 12 | 2012-05-11 | 2021-11-04 |
| Cerebrospinal Fluid Levels of Erlotinib in Patients Receiving Erlotinib For Stage III Non-Small Cell Lung Cancer antitumor drug screening assay - Lung Cancer | Not applicable | Completed | The Cleveland Clinic | 10 | 2004-01-01 | 2011-05-17 |
| Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer paclitaxel, antitumor drug screening assay - Breast Cancer | Phase 2 | Unknown | Oncotech | 100 | 1997-07-01 | 2013-12-19 |
Breast Neoplasms (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Anemia, Refractory, with Excess of Blasts (1) · Breast Neoplasms, Male (1) · Carcinoma, Non-Small-Cell Lung (1) · Congenital Abnormalities (1) · Leukemia, Erythroblastic, Acute (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Lung Neoplasms (1) · Myeloproliferative Disorders (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Substance-Related Disorders (1)
Assiut University (1) · OHSU Knight Cancer Institute (1) · Oncotech (1) · Peking University Cancer Hospital & Institute (1) · The Cleveland Clinic (1) · University of Washington (1)
United States (4) · China (1)
Marc Loriaux (1) · Michael A. Vogelbaum, MD, PhD (1) · Min Jiang (1) · Pamela Becker (1) · Rita S. Mehta, MD (1)
P30CA015704 (1), P30CA043703 (1), R21CA159265 (1)